Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 63.39 M66.74 M69.73 M65.37 M 265.23 M Research & development ———— — Operating income 71.76 M79.67 M82.49 M75.49 M 309.41 M Non-Operating Income, Total 224 K-501 K-10.01 M567 K -9.71 M Interest expense, net of interest capitalized 360 K355 K334 K326 K 1.38 M Non-Operating Income, excl. Interest Expenses -360 K-355 K-334 K-467 K -1.52 M Unusual income/expense 224 K-501 K-10.01 M708 K -9.57 M Pretax income 71.62 M78.81 M72.15 M257.5 M 480.08 M Equity in earnings ———— — Taxes 14.31 M26.92 M15.12 M10.84 M 67.19 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 47.47 M42.21 M46.7 M53.93 M 190.3 M Discontinued operations ———— — Net income 47.47 M42.21 M46.7 M53.93 M 190.3 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 47.47 M42.21 M46.7 M53.93 M 190.3 M Basic earnings per share (Basic EPS) 0.960.860.981.13 3.93 Diluted earnings per share (Diluted EPS) 0.950.860.971.13 3.91 Average basic shares outstanding 49.48 M49.02 M47.88 M48.46 M — Diluted shares outstanding 49.83 M49.26 M48.09 M48.72 M — EBITDA 69.22 M77.3 M79.41 M72.42 M 298.34 M EBIT 61.55 M69.63 M71.82 M64.06 M 267.07 M Cost of revenue 109.2 M122.53 M126.08 M135.32 M 493.13 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 7.67 M7.66 M7.59 M8.35 M 31.27 M